{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T11:30:18Z","timestamp":1779190218687,"version":"3.51.4"},"reference-count":33,"publisher":"The Endocrine Society","issue":"6","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Disease","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007800","name":"Diabetes Research and Training Center","doi-asserted-by":"publisher","award":["DK020595"],"award-info":[{"award-number":["DK020595"]}],"id":[{"id":"10.13039\/100007800","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012499","name":"Chicago Center for Diabetes Translation Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012499","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007234","name":"University of Chicago","doi-asserted-by":"publisher","award":["DK092949"],"award-info":[{"award-number":["DK092949"]}],"id":[{"id":"10.13039\/100007234","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Career Development Program","award":["DK138262"],"award-info":[{"award-number":["DK138262"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Thyroid hormone homeostasis is critical to the metabolic function of cardiovascular tissues. The degree to which the suboptimal treatment of hypothyroidism with levothyroxine (LT4) impacts blood pressure (BP) and blood pressure variability (BPV) is not known.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Determine the relationship between LT4 time above range (TAR) (TSH level &amp;gt;4.5 mIU\/L), time below range (TBR) (TSH &amp;lt;0.4 mIU\/L), and changes in annual mean systolic (SBP) and diastolic blood pressure (DBP) and visit-to-visit BPV.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using longitudinal data from 2203 adult patients treated with LT4, we modeled within-individual changes in annual mean BP and BPV as a function of TAR and TBR (% time). Linear mixed-effect modeling was utilized to allow for differences in observation time between patients. Models were adjusted for sociodemographics, baseline comorbidities, weight, LT4 dose, time, and year of study enrollment. Sensitivity analyses were conducted with wide in-range boundaries (TSH 0.1-10 mIU\/L) and stratification by hypertension at baseline.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In the primary modeling, a 100% increase in TAR was associated with significant increases in annual mean SBP and DBP (+1.8 mmHg, P = .011; +1.0 mmHg, P = .024, respectively). Similarly, a 100% increase in TBR was associated with increases in annual mean SBP and DBP (+2.7 mmHg, P = .004; +1.3 mmHg, P = .034, respectively). However, the expected differences in BP with TAR and TBR diminished in subsequent years. One hundred percent TAR and TBR were associated with small increases in annual visit-to-visit diastolic BPV (+0.67 mmHg, P = .009; +0.85 mmHg, P = .020, respectively).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Suboptimal LT4 treatment was associated with increases in mean BP and BPV, representing potential mediators in the pathway between suboptimal LT4 treatment and cardiovascular disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgaf675","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:42:09Z","timestamp":1765888929000},"page":"e1626-e1633","source":"Crossref","is-referenced-by-count":1,"title":["Suboptimal Levothyroxine Treatment is Associated with Increases in Mean Blood Pressure and Blood Pressure Variability"],"prefix":"10.1210","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0328-1752","authenticated-orcid":false,"given":"Matthew D","family":"Ettleson","sequence":"first","affiliation":[{"name":"Section of Endocrinology, Diabetes, and Metabolism, University of Chicago , Chicago, IL 60637 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikita","family":"Thomas","sequence":"additional","affiliation":[{"name":"Section of General Internal Medicine, University of Chicago , Chicago, IL 60637 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Wan","sequence":"additional","affiliation":[{"name":"Section of General Internal Medicine, University of Chicago , Chicago, IL 60637 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald","family":"Hedeker","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, University of Chicago , Chicago, IL 60637 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne R","family":"Cappola","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Pennsylvania , Philadelphia, PA 19104 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0124-4325","authenticated-orcid":false,"given":"Neda","family":"Laiteerapong","sequence":"additional","affiliation":[{"name":"Section of General Internal Medicine, University of Chicago , Chicago, IL 60637 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio C","family":"Bianco","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Internal Medicine, University of Texas Medical Branch , Galveston, TX 77555 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"issue":"3","key":"2026051819574248200_dgaf675-B1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.2020.9389","article-title":"Effect of levothyroxine on left ventricular ejection fraction in patients with subclinical hypothyroidism and acute myocardial infarction: a randomized clinical trial","volume":"324","author":"Jabbar","year":"2020","journal-title":"JAMA"},{"issue":"6","key":"2026051819574248200_dgaf675-B2","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s11906-003-0060-7","article-title":"Thyroid hormone and blood pressure regulation","volume":"5","author":"Danzi","year":"2003","journal-title":"Curr Hypertens Rep"},{"issue":"5","key":"2026051819574248200_dgaf675-B3","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1210\/jcem.87.5.8464","article-title":"The role of thyroid hormone in blood pressure homeostasis: evidence from short-term hypothyroidism in humans","volume":"87","author":"Fommei","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2026051819574248200_dgaf675-B4","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3389\/fendo.2019.00482","article-title":"Hypertension in thyroid disorders","volume":"10","author":"Berta","year":"2019","journal-title":"Front Endocrinol"},{"issue":"2","key":"2026051819574248200_dgaf675-B5","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4158\/EP13237.OR","article-title":"Association between subclinical hypothyroidism and blood pressure\u2013a meta-analysis of observational studies","volume":"20","author":"Ye","year":"2014","journal-title":"Endocr Pract"},{"issue":"10","key":"2026051819574248200_dgaf675-B6","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1038\/hr.2011.91","article-title":"Blood pressure levels in patients with subclinical thyroid dysfunction: a meta-analysis of cross-sectional data","volume":"34","author":"Cai","year":"2011","journal-title":"Hypertens Res"},{"issue":"12","key":"2026051819574248200_dgaf675-B7","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1210\/clinem\/dgae294","article-title":"TSH trajectories during levothyroxine treatment in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) cohort","volume":"109","author":"Ettleson","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2026051819574248200_dgaf675-B8","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/qjmed\/hcq222","article-title":"Adequacy of thyroid hormone replacement in a general population","volume":"104","author":"Okosieme","year":"2011","journal-title":"QJM"},{"issue":"6","key":"2026051819574248200_dgaf675-B9","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1530\/EJE-19-0006","article-title":"Duration of over- and under-treatment of hypothyroidism is associated with increased cardiovascular risk","volume":"180","author":"Lillevang-Johansen","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2026051819574248200_dgaf675-B10","doi-asserted-by":"crossref","first-page":"e2211863","DOI":"10.1001\/jamanetworkopen.2022.11863","article-title":"Association of thyroid hormone treatment intensity with cardiovascular mortality among US veterans","volume":"5","author":"Evron","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2026051819574248200_dgaf675-B11","doi-asserted-by":"crossref","first-page":"l4892","DOI":"10.1136\/bmj.l4892","article-title":"Thyroid replacement therapy, thyroid stimulating hormone concentrations, and long term health outcomes in patients with hypothyroidism: longitudinal study","volume":"366","author":"Thayakaran","year":"2019","journal-title":"BMJ"},{"key":"2026051819574248200_dgaf675-B12","doi-asserted-by":"crossref","first-page":"i4098","DOI":"10.1136\/bmj.i4098","article-title":"Blood pressure variability and cardiovascular disease: systematic review and meta-analysis","volume":"354","author":"Stevens","year":"2016","journal-title":"BMJ"},{"issue":"1","key":"2026051819574248200_dgaf675-B13","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/HJH.0000000000001159","article-title":"Visit-to-visit blood pressure variability is a risk factor for all-cause mortality and cardiovascular disease: a systematic review and meta-analysis","volume":"35","author":"Wang","year":"2017","journal-title":"J Hypertens"},{"issue":"(2)","key":"2026051819574248200_dgaf675-B14","doi-asserted-by":"crossref","first-page":"e484","DOI":"10.1210\/clinem\/dgaf393","article-title":"Measuring hypothyroidism disease control using a TSH-based \u201ctime-in-range\u201d","volume":"111","author":"Ettleson","year":"2026","journal-title":"J Clin Endocrinol Metab"},{"issue":"(03","key":"2026051819574248200_dgaf675-B15","first-page":"236","article-title":"A method to determine the optimal intensity of oral anticoagulant therapy","volume":"69","author":"Rosendaal","year":"1993","journal-title":"Thromb Haemost"},{"key":"2026051819574248200_dgaf675-B16","doi-asserted-by":"crossref","first-page":"925571","DOI":"10.3389\/fcvm.2022.925571","article-title":"Rosendaal linear interpolation method appraising of time in therapeutic range in patients with 12-week follow-up interval after mechanical heart valve replacement","volume":"9","author":"Zhu","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"4","key":"2026051819574248200_dgaf675-B17","doi-asserted-by":"crossref","first-page":"e009258","DOI":"10.1161\/CIRCOUTCOMES.122.009258","article-title":"Quantifying blood pressure visit-to-visit variability in the real-world setting: a retrospective cohort study","volume":"16","author":"Lu","year":"2023","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"4","key":"2026051819574248200_dgaf675-B18","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/HJH.0000000000003363","article-title":"Blood pressure variability: methodological aspects, clinical relevance and practical indications for management - a European Society of Hypertension position paper\u2217","volume":"41","author":"Parati","year":"2023","journal-title":"J Hypertens"},{"issue":"2","key":"2026051819574248200_dgaf675-B19","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1210\/endrev\/bnab031","article-title":"Optimal thyroid hormone replacement","volume":"43","author":"Jonklaas","year":"2022","journal-title":"Endocr Rev"},{"key":"2026051819574248200_dgaf675-B20","doi-asserted-by":"crossref","unstructured":"Ettleson MD . 2025. Suboptimal levothyroxine treatment is associated with increases in mean blood pressure and blood pressure variability: Supplemental Tables. Zenodo. 10.5281\/zenodo.17654503.","DOI":"10.1210\/clinem\/dgaf675"},{"issue":"3","key":"2026051819574248200_dgaf675-B21","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1210\/jc.2006-2208","article-title":"Association between blood pressure and serum thyroid-stimulating hormone concentration within the reference range: a population-based study","volume":"92","author":"Asvold","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026051819574248200_dgaf675-B22","first-page":"58","article-title":"Medication nonadherence: an unrecognized cardiovascular risk factor","volume":"9","author":"Munger","year":"2007","journal-title":"MedGenMed"},{"issue":"15","key":"2026051819574248200_dgaf675-B23","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.106.678326","article-title":"Thyroid disease and the heart","volume":"116","author":"Klein","year":"2007","journal-title":"Circulation"},{"issue":"2","key":"2026051819574248200_dgaf675-B24","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1152\/jappl.1967.22.2.207","article-title":"Hemodynamic effects of peripheral vasoconstriction in normal and thyrotoxic subjects","volume":"22","author":"Theilen","year":"1967","journal-title":"J Appl Physiol"},{"issue":"8","key":"2026051819574248200_dgaf675-B25","first-page":"3264","article-title":"Subclinical hyperthyroidism: the cardiovascular point of view","volume":"25","author":"Vidili","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2026051819574248200_dgaf675-B26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ahj.2020.09.016","article-title":"Levothyroxine dose and risk of atrial fibrillation: a nested case-control study","volume":"232","author":"Gong","year":"2021","journal-title":"Am Heart J"},{"issue":"19","key":"2026051819574248200_dgaf675-B27","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJM199411103311901","article-title":"Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons","volume":"331","author":"Sawin","year":"1994","journal-title":"N Engl J Med"},{"issue":"10","key":"2026051819574248200_dgaf675-B28","doi-asserted-by":"crossref","first-page":"e3890","DOI":"10.1210\/clinem\/dgab444","article-title":"Thyroid hormone therapy and incident stroke","volume":"106","author":"Papaleontiou","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2026051819574248200_dgaf675-B29","doi-asserted-by":"crossref","first-page":"9G","DOI":"10.1016\/S0002-9149(03)00227-3","article-title":"Atrial fibrillation: hypertension as a causative agent, risk factor for complications, and potential therapeutic target","volume":"91","author":"Healey","year":"2003","journal-title":"Am J Cardiol"},{"issue":"2","key":"2026051819574248200_dgaf675-B30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1089\/thy.2009.0311","article-title":"Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer","volume":"20","author":"Biondi","year":"2010","journal-title":"Thyroid"},{"key":"2026051819574248200_dgaf675-B31","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwaf546","article-title":"Visit-to-visit blood pressure variability and cardiovascular outcomes: a systematic review and dose-response meta-analysis","author":"Lukitasari","journal-title":"Eur J Prev Cardiol"},{"issue":"12","key":"2026051819574248200_dgaf675-B32","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1089\/thy.2006.0235","article-title":"Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002)","volume":"17","author":"Aoki","year":"2007","journal-title":"Thyroid"},{"issue":"5","key":"2026051819574248200_dgaf675-B33","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1530\/EJE-13-0459","article-title":"Changes in the prevalence of hypothyroidism: the HUNT Study in Norway","volume":"169","author":"Asvold","year":"2013","journal-title":"Eur J Endocrinol"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaf675\/65930480\/dgaf675.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/6\/e1626\/65930480\/dgaf675.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/6\/e1626\/65930480\/dgaf675.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T23:57:53Z","timestamp":1779148673000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/111\/6\/e1626\/8382204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":33,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,12,17]]},"published-print":{"date-parts":[[2026,5,19]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaf675","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2025,12,17]]}}}